Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi,1
Yong Zheng,1
Kyoko Nakamura,1
Kesley Attridge,1
Claire Manzotti,1
Emily M. Schmidt,1
Jennifer Baker,1
Louisa E. Jeffery,1
Satdip Kaur,1
Zoe Briggs,1
Tie Z. Hou,1
Clare E. Futter,2
Graham Anderson,1
Lucy S.K. Walker,1
David M. Sansom1,*
Abstract:
Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an essential negative regulator of T cell immune responses whose mechanism of action is the subject of debate. CTLA-4 shares two ligands (CD80 and CD86) with a stimulatory receptor, CD28. Here, we show that CTLA-4 can capture its ligands from opposing cells by a process of trans-endocytosis. After removal, these costimulatory ligands are degraded inside CTLA-4–expressing cells, resulting in impaired costimulation via CD28. Acquisition of CD86 from antigen-presenting cells is stimulated by T cell receptor engagement and observed in vitro and in vivo. These data reveal a mechanism of immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the cell-extrinsic depletion of ligands, accounting for many of the known features of the CD28–CTLA-4 system.
1 Medical Research Council (MRC) Centre for Immune Regulation, School of Immunity and Infection, Institute of Biomedical Research, University of Birmingham Medical School, Birmingham B15 2TT, UK. 2 Department of Cell Biology, University College London Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
* To whom correspondence should be addressed. E-mail: d.m.sansom{at}bham.ac.uk
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Shimon Sakaguchi and Kajsa Wing (29 April 2011) Science332 (6029), 542.
[DOI: 10.1126/science.1206122] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
Kristen L. Mueller (3 May 2011) Sci. Signal.4 (171), ec125.
[DOI: 10.1126/scisignal.4171ec125] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
T. Yamaguchi, A. Kishi, M. Osaki, H. Morikawa, P. Prieto-Martin, K. Wing, T. Saito, and S. Sakaguchi (2013)
PNAS
110, E2116-E2125
|Abstract »|Full Text »|PDF »
Regulatory Cells and Transplantation Tolerance.
S. P. Cobbold and H. Waldmann (2013)
Cold Spring Harb Perspect Med
3, a015545
|Abstract »|Full Text »|PDF »
Structure and Interactions of the Human Programmed Cell Death 1 Receptor.
X. Cheng, V. Veverka, A. Radhakrishnan, L. C. Waters, F. W. Muskett, S. H. Morgan, J. Huo, C. Yu, E. J. Evans, A. J. Leslie, et al. (2013)
J. Biol. Chem.
288, 11771-11785
|Abstract »|Full Text »|PDF »
Antigen Choice Determines Vaccine-Induced Generation of Immunogenic versus Tolerogenic Dendritic Cells That Are Marked by Differential Expression of Pancreatic Enzymes.
A. M. Farkas, D. M. Marvel, and O. J. Finn (2013)
J. Immunol.
190, 3319-3327
|Abstract »|Full Text »|PDF »
Functional Characterization of T Cell Populations in a Mouse Model of Chronic Obstructive Pulmonary Disease.
B. L. Eppert, B. W. Wortham, J. L. Flury, and M. T. Borchers (2013)
J. Immunol.
190, 1331-1340
|Abstract »|Full Text »|PDF »
CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE-/- mice.
K. Ma, S. Lv, B. Liu, Z. Liu, Y. Luo, W. Kong, Q. Xu, J. Feng, and X. Wang (2013)
Cardiovasc Res
97, 349-359
|Abstract »|Full Text »|PDF »
Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses.
L. E. Jeffery, A. M. Wood, O. S. Qureshi, T. Z. Hou, D. Gardner, Z. Briggs, S. Kaur, K. Raza, and D. M. Sansom (2012)
J. Immunol.
189, 5155-5164
|Abstract »|Full Text »|PDF »
Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
Regulatory T Cell Induction, Migration, and Function in Transplantation.
B. E. Burrell, Y. Nakayama, J. Xu, C. C. Brinkman, and J. S. Bromberg (2012)
J. Immunol.
189, 4705-4711
|Abstract »|Full Text »|PDF »
Activation of the noncanonical NF-{kappa}B pathway by HIV controls a dendritic cell immunoregulatory phenotype.
O. Manches, M. V. Fernandez, J. Plumas, L. Chaperot, and N. Bhardwaj (2012)
PNAS
109, 14122-14127
|Abstract »|Full Text »|PDF »
Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell.
J. E. D. Thaventhiran, A. Hoffmann, L. Magiera, M. de la Roche, H. Lingel, M. Brunner-Weinzierl, and D. T. Fearon (2012)
PNAS
109, E2223-E2229
|Abstract »|Full Text »|PDF »
Cutting Edge: Cell-Extrinsic Immune Regulation by CTLA-4 Expressed on Conventional T Cells.
C. J. Wang, R. Kenefeck, L. Wardzinski, K. Attridge, C. Manzotti, E. M. Schmidt, O. S. Qureshi, D. M. Sansom, and L. S. K. Walker (2012)
J. Immunol.
189, 1118-1122
|Abstract »|Full Text »|PDF »
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans.
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention.
W. J. Norde, W. Hobo, R. van der Voort, and H. Dolstra (2012)
Blood
120, 728-736
|Abstract »|Full Text »|PDF »
New Anticancer Immunotherapies.
H. A. FRANKS, Q. WANG, and P. M. PATEL (2012)
Anticancer Res
32, 2439-2453
|Abstract »|Full Text »|PDF »
Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200.
K. Misstear, S. A. Chanas, S. A. R. Rezaee, R. Colman, L. L. Quinn, H. M. Long, O. Goodyear, J. M. Lord, A. D. Hislop, and D. J. Blackbourn (2012)
J. Virol.
86, 6246-6257
|Abstract »|Full Text »|PDF »
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells.
X. Tai, F. Van Laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow, A. Adams, L. Granger, M. Kruhlak, T. Lindsten, C. B. Thompson, et al. (2012)
Blood
119, 5155-5163
|Abstract »|Full Text »|PDF »
Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance.
M. P. Matheu, Y. Su, M. L. Greenberg, C. A. Blanc, I. Parker, D. W. Scott, and M. D. Cahalan (2012)
PNAS
109, E1258-E1266
|Abstract »|Full Text »|PDF »
Sarcoidosis in a Patient with Metastatic Melanoma Sequentially Treated with Anti-CTLA-4 Monoclonal Antibody and Selective BRAF Inhibitor.
S. WILGENHOF, V. MORLION, A. C. SEGHERS, S. DU FOUR, E. VANDERLINDEN, S. HANON, F. VANDENBROUCKE, H. EVERAERT, and B. NEYNS (2012)
Anticancer Res
32, 1355-1359
|Abstract »|Full Text »|PDF »
Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation.
O. S. Qureshi, S. Kaur, T. Z. Hou, L. E. Jeffery, N. S. Poulter, Z. Briggs, R. Kenefeck, A. K. Willox, S. J. Royle, J. Z. Rappoport, et al. (2012)
J. Biol. Chem.
287, 9429-9440
|Abstract »|Full Text »|PDF »
Immunotherapy earns its spot in the ranks of cancer therapy.
Higher proportions of circulating FOXP3+ and CTLA-4+ regulatory T cells are associated with lower fractions of memory CD4+ T cells in infants.
H. Rabe, A.-C. Lundell, K. Andersson, I. Adlerberth, A. E. Wold, and A. Rudin (2011)
J. Leukoc. Biol.
90, 1133-1140
|Abstract »|Full Text »|PDF »
Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells.
M. Nakayama, K. Takeda, M. Kawano, T. Takai, N. Ishii, and K. Ogasawara (2011)
PNAS
108, 18360-18365
|Abstract »|Full Text »|PDF »
Regulatory T Cells Selectively Control CD8+ T Cell Effector Pool Size via IL-2 Restriction.
W. Kastenmuller, G. Gasteiger, N. Subramanian, T. Sparwasser, D. H. Busch, Y. Belkaid, I. Drexler, and R. N. Germain (2011)
J. Immunol.
187, 3186-3197
|Abstract »|Full Text »|PDF »